Zenotech Laboratories Ltd (BSE: 532039) is a Hyderabad, Telangana-based company in the Biological Products industry. With a market capitalisation of ₹241 Cr, it ranks #2,498 by market cap among the 6,197 Indian listed companies on FinBizNet, and #3 of 5 in Biological Products. At ₹39.01 (as of 16 Nov 2026), the share price is 24.6% below its 52-week high of ₹51.74 and 16.3% above its 52-week low of ₹33.55. The share price is down 22.5% over one year and down 11.4% over three months.
| Current Price | ₹39.01 |
|---|---|
| Market Cap | ₹241 Cr |
| BSE Code | 532039 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology |
| Sub-Industry | Biotechnology > Biological Products |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -1.12% |
| Return on Assets | 1.55% |
| 52-Week Range | ₹33.55 – ₹51.74 |
| 1-Year Price Change | -22.5% |
| 3-Month Price Change | -11.4% |
| Beta (1Y) | 0.64 |
| Headquarters | Hyderabad, Telangana |
| Website | zenotechlab.com |
Delivery averaged 83.1% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.
1. Pharmaceuticals-This segment engages in the manufacture of pharmaceutical specialty generic injectable products for therapy areas, such as oncology and anesthesiology.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Biocon Limited | ₹59,929 Cr | 131.2 | 1.15% | ₹4,389 Cr | -4.3% |
| Hester Biosciences Ltd | ₹1,985 Cr | 35.7 | 16.55% | ₹98 Cr | +46.0% |
| Zenotech Laboratories Ltd | ₹241 Cr | n/m | -1.12% | — | -22.5% |
| Transgene Biotek Ltd. | ₹19 Cr | n/m | -17.96% | ₹0 Cr | -22.1% |
| Hindustan Bio Sciences Ltd | ₹7 Cr | n/m | -9.12% | — | -0.4% |
Listed by market capitalisation. Ratios are shown for context only.
Zenotech Laboratories Ltd is trading at ₹39.01, with a market capitalisation of ₹241 Cr.
Zenotech Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Biotechnology space (Biotechnology > Biological Products).
Zenotech Laboratories Ltd has a return on equity of -1.12%.
Zenotech Laboratories Ltd is listed on the BSE under the scrip code 532039.
Zenotech Laboratories Ltd's share price is down 22.5% over one year and down 11.4% over three months. Its 52-week range is ₹33.55 to ₹51.74.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.